View Post

The shape of nanoparticles in body fluids may help identify the type of cancer

In Clinical Studies News by Barbara Jacoby

Source: Nagoya University From: sciencedaily.com A recent study by scientists from Japanese universities has shown that the shape of cell-derived nanoparticles, known as “extracellular vesicles” (EVs), in body fluids could be a biomarker for identifying types of cancer. In the study, the scientists successfully measured the shape distributions of EVs derived from liver, breast, and colorectal cancer cells, showing that …

View Post

Promising new research on aggressive breast cancer

In In The News by Barbara Jacoby

Source: University of Montreal From: eurekalert.org Better treatments of HER2-positive breast cancer are closer at hand, thanks to new research by a team led by Université de Montréal professor Jean-François Côté at the cytoskeleton organization and cell-migration research unit of the UdeM-affiliated Montreal Clinical Research Institute. Published in PNAS, the journal of the U.S. National Academy of Sciences, the new …

View Post

New Breast Cancer Skills Program for Patients Released by American College of Surgeons

In Clinical Studies News by Barbara Jacoby

By: American College of Surgeons (ACS) From: newswise.com Breast cancer patients have access to evidence-based knowledge, checklists, and skills training to support them from surgery preparation through recovery The American College of Surgeons (ACS) Surgical Skills Patient Education Program has launched a new kit for breast cancer patients that will help guide them from diagnosis to recovery. The ACS Surgical …

View Post

How to avoid treatment you don’t need

In In The News by Barbara Jacoby

By: Marshall Allencancer From: kevinmd.com The American epidemic of unnecessary medical treatment is one of the reasons your health care costs keep going up. Experts estimate it’s wasting hundreds of billions of dollars a year. That’s not some number that’s detached from you and me. We pay higher monthly insurance premiums and larger deductibles because of all this care the …

View Post

Updated recommendations for managing hereditary breast cancer

In Clinical Studies News by Barbara Jacoby

Source: Health Day From: medicalxpress.com One year of adjuvant olaparib should be offered to patients with high-risk early-stage human epidermal growth factor receptor 2 (HER2)-negative breast cancer and germline BRCA mutations after completion of (neo)adjuvant chemotherapy and local treatment, according to a rapid recommendation update published by the American Society for Clinical Oncology (ASCO). Following presentation of the results from …

View Post

Summer Travel Tips for Cancer Patients

In In The News by Barbara Jacoby

By: Tampa Bay Radiation Oncology With your doctor’s supervision, outdoor activities like traveling can be very beneficial to your health, well-being and healing while receiving cancer treatment. You may need to take a few precautions when traveling because of a potentially weakened immune system and tendency toward fatigue. But, setting out on vacation this summer can still be enjoyable and …

View Post

Mature Data Drive New Insights With Novel Agents in Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Caroline Seymour From: onclive.com The data with CDK4/6 inhibitors, PI3K inhibitors, antibody-drug conjugates, and PARP inhibitors in metastatic breast cancer continue to support their use in the clinic. The data with CDK4/6 inhibitors, PI3K inhibitors, antibody-drug conjugates (ADCs), and PARP inhibitors in metastatic breast cancer continue to support their use in the clinic, explained Lisa A. Carey, MD, FASCO. …

View Post

‘Tumor avatars’ predict patients’ response to immunotherapy

In In The News by Barbara Jacoby

Source: Netherlands Cancer Institute Tumor fragments in the lab are able to predict whether the corresponding real-life patients will benefit from immunotherapy. “We’ve solved a major problem many scientists had been facing: preserving a tumors original composition and structure outside of the patient in the lab”, says cancer researcher Daniela Thommen from the Netherlands Cancer Institute. On 8 July, the …

View Post

Savvy Cooperative: Patients who were Part of a Clinical Trial During the COVID-19 Pandemic

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Scope: We need patients who were part of a clinical trial during the COVID-19 pandemic Eligibility Criteria: Were part of a clinical trial during covid Proof of diagnosis/participation will be required to participate Geography: USA Details: Video interview with Savvy that Savvy will edit down into a highlight reel to be used in a pharmaceutical company’s internal meeting as well …

View Post

FDA Supports Continued Development of Oral Paclitaxel/Encequidar in Metastatic Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Kristi Rosa From: onclive.com Athenex, Inc. held a Type A meeting with the FDA to discuss the deficiencies raised in the complete response letter issued in March 2021 for the new drug application for oral paclitaxel plus encequidar in the treatment of patients with metastatic breast cancer. Athenex, Inc. held a Type A meeting with the FDA to discuss …